Wolverine Trading’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $16.1M | Buy |
79,900
+40,100
| +101% | +$7.11M | 0.01% | 691 |
|
|
2025
Q2 | $6.91M | Buy |
39,800
+7,500
| +23% | +$1.13M | 0.01% | 867 |
|
|
2025
Q1 | $4.3M | Sell |
32,300
-1,700
| -5% | -$224K | 0.01% | 1071 |
|
|
2024
Q4 | $4.26M | Sell |
34,000
-34,800
| -51% | -$5.17M | ﹤0.01% | 1330 |
|
|
2024
Q3 | $11.2M | Buy |
68,800
+19,400
| +39% | +$2.93M | 0.01% | 640 |
|
|
2024
Q2 | $6.57M | Buy |
49,400
+18,400
| +59% | +$2.21M | 0.01% | 825 |
|
|
2024
Q1 | $3.26M | Buy |
31,000
+3,200
| +12% | +$288K | ﹤0.01% | 1273 |
|
|
2023
Q4 | $2.1M | Buy |
27,800
+12,000
| +76% | +$761K | ﹤0.01% | 1688 |
|
|
2023
Q3 | $1.04M | Buy |
+15,800
| New | +$1.18M | ﹤0.01% | 2089 |
|
|
2023
Q1 | – | Sell |
-33,400
| Closed | -$1.63M | – | 4939 |
|
|
2022
Q4 | $1.63M | Buy |
33,400
+27,700
| +486% | +$1.28M | ﹤0.01% | 1522 |
|
|
2022
Q3 | $302K | Sell |
5,700
-2,200
| -28% | -$131K | ﹤0.01% | 3145 |
|
|
2022
Q2 | $447K | Sell |
7,900
-57,300
| -88% | -$3.99M | ﹤0.01% | 2653 |
|
|
2022
Q1 | $5.67M | Buy |
65,200
+26,300
| +68% | +$2.16M | 0.01% | 1001 |
|
|
2021
Q4 | $3.19M | Buy |
38,900
+20,400
| +110% | +$1.49M | ﹤0.01% | 1477 |
|
|
2021
Q3 | $1.27M | Sell |
18,500
-100
| -0.5% | -$7.09K | ﹤0.01% | 2685 |
|
|
2021
Q2 | $1.23M | Buy |
+18,600
| New | +$1.15M | ﹤0.01% | 2542 |
|
|
2021
Q1 | – | Sell |
-60,500
| Closed | -$2.41M | – | 6395 |
|
|
2020
Q4 | $2.41M | Sell |
60,500
-11,800
| -16% | -$381K | ﹤0.01% | 1548 |
|
|
2020
Q3 | $1.7M | Buy |
72,300
+7,100
| +11% | +$181K | ﹤0.01% | 1600 |
|
|
2020
Q2 | $1.19M | Buy |
65,200
+13,800
| +27% | +$272K | ﹤0.01% | 1847 |
|
|
2020
Q1 | $819K | Sell |
51,400
-35,900
| -41% | -$1.03M | ﹤0.01% | 2120 |
|
|
2019
Q4 | $3.3M | Sell |
87,300
-21,200
| -20% | -$635K | 0.01% | 1436 |
|
|
2019
Q3 | $2.37M | Sell |
108,500
-32,500
| -23% | -$692K | 0.01% | 1319 |
|
|
2019
Q2 | $2.91M | Buy |
141,000
+12,200
| +9% | +$281K | 0.01% | 1255 |
|
|
2019
Q1 | $3.71M | Sell |
128,800
-48,900
| -28% | -$1.21M | 0.01% | 1063 |
|
|
2018
Q4 | $3.07M | Buy |
177,700
+27,700
| +18% | +$670K | 0.01% | 1108 |
|
|
2018
Q3 | $4.27M | Buy |
150,000
+88,600
| +144% | +$2.93M | 0.01% | 1083 |
|
|
2018
Q2 | $1.49M | Hold |
61,400
| – | – | ﹤0.01% | 1853 |
|
|
2018
Q1 | $1.49M | Sell |
61,400
-164,400
| -73% | -$3.27M | ﹤0.01% | 1853 |
|
|
2017
Q4 | $3.42M | Buy |
225,800
+5,500
| +2% | +$77.4K | 0.01% | 1122 |
|
|
2017
Q3 | $3.62M | Buy |
+220,300
| New | +$3.74M | 0.01% | 955 |
|
|
2017
Q2 | – | Sell |
-200,700
| Closed | -$3.65M | – | 4959 |
|
|
2017
Q1 | $3.65M | Buy |
200,700
+50,800
| +34% | +$942K | 0.02% | 819 |
|
|
2016
Q4 | $2.23M | Sell |
149,900
-9,000
| -6% | -$161K | 0.01% | 1261 |
|
|
2016
Q3 | $3.5M | Buy |
158,900
+56,000
| +54% | +$1.46M | 0.02% | 941 |
|
|
2016
Q2 | $2.85M | Buy |
+102,900
| New | +$3.04M | 0.02% | 896 |
|
Other funds holding THC
GCM
Wolverine Trading's THC Position: Q3 2025 in Review
Wolverine Trading reduced its Tenet Healthcare (THC) stake by 25% in Q3 2025, selling an estimated $194K and leaving 3,249 shares worth $654K. The position accounts for ﹤0.01% of the portfolio, ranked #3382.
Wolverine Trading first reported a position in THC in Q3 2016 and has held it in 24 quarters since. The position peaked at $2.73M in Q4 2019. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.
- Wolverine Trading held 3,249 shares of Tenet Healthcare worth $654K as of Q3 2025.
- Wolverine Trading sold 1,094 Tenet Healthcare shares in Q3 2025, an estimated $194K.
- Tenet Healthcare made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3382 holding.
- Wolverine Trading first reported a position in Tenet Healthcare in Q3 2016 and has held it in 24 quarters since.
- Wolverine Trading's Tenet Healthcare position peaked at $2.73M in Q4 2019.
- 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.